全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...
Health  2018 

Seroprevalence, Type-Specific of Herpes Simplex Virus and Associated Risk Factors among Women of Child Bearing Age in Kogi State, Nigeria

DOI: 10.4236/health.2018.107075, PP. 1006-1017

Keywords: HSV-1/HSV-2 Antibody, Infection, Women, Kogi State, Nigeria

Full-Text   Cite this paper   Add to My Lib

Abstract:

Background: Viruses of the Herpes viridae family infect 90% of the Earth’s population. Humans are the hosts of at least nine unique herpes viruses. Aim: This study is aimed at evaluating the seroprevalence of type specific herpes simplex virus infection and the associated risk factors in a cross-section of asymptomatic healthy women of childbearing age in Kogi state, Nigeria. Methodology: A total of 330 females of child bearing age (15 - 49 years) participated in this study. They were recruited from various local government areas of three Senatorial districts of Kogi state. Blood samples were collected from participants and analyzed for HSV-1 and HSV-2 antibodies (IgG) quantitatively with ELISA kit. Results: The overall prevalence of HSV was 76.7%. Data further show that majority (96.4%) of the population studied had HSV-1, while 77% had HSV-2 infections. Results also showed that the young adults indicated prevalence of 95.7% for HSV-1 and 74.7% for HSV-2, while in the middle aged, the prevalence were 98.6% for HSV-1, and 84.9% for HSV-2. 99.2% of the married women were positive for HSV-1, while 86.9% were positive for HSV-2. 94.5% of the unmarried women were positive for HSV-1, while 70.5% were positive for HSV-2. The risk of HVS-1 or VS-2 infections was not associated with age, age of first sexual exposure and number sex partners before marriage. Married women were at greater risk for HSV-1 (p = 0.03) and HSV-2 (p ≤ 0.001) infections compared to the unmarried women. Conclusion: The prevalence of the HSV-1 and HSV-2 infections was high among asymptomatic healthy women of childbearing age in Kogi state, Nigeria. Efforts should be made to increase the awareness of HSV infection among the child bearing populace.

References

[1]  Wald, A. and Corey, L. (2007) Chapter 36: Persistence in the Population: Epidemiology, Transmission. Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis, Cambridge University Press, Cambridge.
[2]  Looker, K.J., Garnett, G.P. and Schmid, G.P. (2008) An Estimate of the Global Prevalence and Incidence of Herpes Simplex Virus Type 2 Infection. Bulletin of the World Health Organization, 86, 737-816.
https://doi.org/10.2471/BLT.07.046128
[3]  Oni, A.A., Adu, F.D., Ekweozor, C.C. and Bakare, R.A. (1996) Genital Herpes Simplex Virus Infection in Females in Ibadan Nigeria. West African Journal of Medicine, 15, 107-110.
[4]  Handsfield, H.H. (2000) Public Health Strategies to Prevent Genital Herpes: Where Do We Stand? Current Infectious Disease Reports, 2, 25-30.
https://doi.org/10.1007/s11908-000-0084-y
[5]  Whitley, R.W. and Roizman, B. (2001) Herpes Simplex Virus Infections. Lancet, 357, 1513.
https://doi.org/10.1016/S0140-6736(00)04638-9
[6]  Nahmias, A.J., Lee, F.K. and Beckmanahmias, S. (1990) Sera-Epidemiological and -Sociological Patterns of Herpessimplex Virus Infection in the World. Scandinavian Journal of Infectious Diseases. Supplementum, 69, 19-36.
[7]  Fleming, D.T. and Wasserheit, J.N. (1999) From Epidemiological Synergy to Public Health Policy and Practice: The Contribution of Other Sexually Transmitted Diseases to Sexual Transmission of HIV Infection. Sexually Transmitted Infections, 75, 3-17.
https://doi.org/10.1136/sti.75.1.3
[8]  Fatahzadeh, M. and Schwartz, R.A. (2007) Human Herpes Simplex Virus Infections: Epidemiology, Pathogenesis, Symptomatology, Diagnosis, and Management. Journal of the American Academy of Dermatology, 57, 737-766.
https://doi.org/10.1016/j.jaad.2007.06.027
[9]  CDC: Genital Herpes Rates Still High. Centers for Disease Control and Prevention.
[10]  UPDATE: CDC Stands Behind Report That Half of Black Women Have Herpes. NewsOne.
[11]  Herpes Simplex. University of Maryland Medical Center.
[12]  LEARN ABOUT HERPES > Fast Facts. ASHA Herpes Resource Center.
[13]  STD Facts-Genital Herpes. Centers for Disease Control and Prevention.
[14]  Herpes. Stanford University Sexual Health Peer Resource Center.
[15]  Ojinmah, U.R., Nnoruka, E.N., Ozoh, G.A., Onyekonwu, C.L. and Aguwa, E.N. (2012) Herpes Simplex Virus Type 2 Infection among Females in Enugu, Enugu State. Nigerian Journal of Medicine, 21, 394-403.
[16]  Shaibu, A.M., Aminu, M., Musa, B.O.P. and Bugaje, M.A. (2014) Seroprevalence of IgG Antibodies to Herpes Simplex Virus Type-1 in Nigerian Children. Nigerian Journal of Medicine, 23, 40-45.
[17]  Pebody, R.G., Andrews, N., Brown, D., et al. (2004) The Seroepidemiology of Herpes Simplex Virus Type 1 and 2 in Europe. Sexually Transmitted Infections, 80, 185-191.
https://doi.org/10.1136/sti.2003.005850
[18]  Smith, J.S., Herrero, R., Munoz, N., et al. (2001) Prevalence and Risk Factors for Herpes Simplex Virus Type 2 Infections among Middle-Age Women in Brazil and the Philippines. Sexually Transmitted Diseases, 28, 187-194.
https://doi.org/10.1097/00007435-200104000-00001
[19]  Ibrahim, A.I., Kouwatli, K.M. and Obeid, M.T. (2000) Frequency of Herpes Simplex Virus in Syria Based on Type-Specific Serological Assay. Saudi Medical Journal, 21, 355-360.
[20]  Cunningham, A.L., Taylor, R., Taylor, J., Marks, C., Shaw, J. and Mindel, A. (2006) Prevalence of Infection with Herpes Simplex Virus Types 1 and 2 in Australia: A Nationwide Population Based Survey. Sexually Transmitted Infections, 82, 164-168.
https://doi.org/10.1136/sti.2005.016899
[21]  Patrick, D.M., Dawar, M., Cook, D.A., Krajden, M., Ng, H.C. and Rekart, M.L. (2001) Antenatal Seroprevalence of Herpes Simplex Virus Type 2 (HSV-2) in Canadian Women: HSV-2 Prevalence Increases throughout the Reproductive Years. Sexually Transmitted Diseases, 28, 424-428.
https://doi.org/10.1097/00007435-200107000-00011
[22]  Kaur, R., Gupta, N. and Baveja, U.K. (2005) Seroprevalence of HSV-1/HSV-2 Infections in Family Planning Clinic Attenders. The Journal of Communicable Diseases, 37, 307-309.
[23]  Davidovici, B.B., Green, M., Marouni, M.J., Bassal, R., Pimenta, J.M. and Cohen, D. (2006) Seroprevalence of Herpes Simplex Virus 1 and 2 and Correlates of Infection in Israel. Journal of Infection, 52, 367-373.
https://doi.org/10.1016/j.jinf.2005.08.005
[24]  Weiss, H. (2004) Epidemiology of Herpes Simplex Virus Type 2 Infection in the Developing World. Herpes, 11, 24A-35A.
[25]  Patnaik, P., Herrero, R., Morrow, R.A., et al. (2007) Type-Specific Seroprevalence of Herpes Simplex Virus Type 2 and Associated Risk Factors in Middle-Aged Women from 6 Countries: The IARC Multicentric Study. Sexually Transmitted Diseases, 34, 1019-1024.
https://doi.org/10.1097/OLQ.0b013e31811f4118
[26]  Dolar, N., Serdaroglu, S., Yilmaz, G. and Ergin, S. (2006) Seroprevalence of Herpes Simplex Virus Type 1 and Type 2 in Turkey. Journal of the European Academy of Dermatology and Venereology, 20, 1232-1236.
https://doi.org/10.1111/j.1468-3083.2006.01766.x
[27]  Abuharfeil, N. and Meqdam, M.M. (2000) Seroepidemiologic Study of Herpes Simplex Virus Type 2 and Cytomegalovirus among Young Adults in Northern Jordan. New Microbiologica, 23, 235-239.
[28]  Lyttle, P.H. (1994) Surveillance Report: Disease Trends at New Zealand Sexually Transmitted Disease Clinics 1977-1993. Genitourinary Medicine, 70, 329-335.
https://doi.org/10.1136/sti.70.5.329
[29]  Xu, F., Sternberg, M.R., Gottlieb, S.L., Berman, S.M., Markowitz, L.E. and Forhan, S.E. (2010) Seroprevalence of Herpes Simplex Virus Type 2 among Persons Aged 14-49 Years—United States, 2005-2008. Morbidity and Mortality Weekly Report, 59, 456-459.
[30]  Howard, M., Sellors, J.W., Jang, D., et al. (2003) Regional Distribution of Antibodies to Herpes Simplex Virus Type 1 (HSV-1) and HSV-2 in Men and Women in Ontario, Canada. Journal of Clinical Microbiology, 41, 84-89.
https://doi.org/10.1128/JCM.41.1.84-89.2003
[31]  Shin, H.S., Park, J.J., Chu, C., et al. (2007) Herpes Simplex Virus Type 2 Seroprevalence in Korea: Rapid Increase of HSV-2 Seroprevalence in the 30s in the Southern Part. Journal of Korean Medical Science, 22, 957-962.
https://doi.org/10.3346/jkms.2007.22.6.957
[32]  Smith, J.S. and Robinson, J.N. (2002) Age-Specific Prevalence of Infection with Herpes Simplex Virus Types 2 and 1: A Global Review. The Journal of Infectious Diseases, 186, S3-S28.
https://doi.org/10.1086/343739
[33]  Patel, P., Bush, T., Mayer, K.H., Desai, S., Henry, K., Overton, E.T., et al. (2012) Prevalence and Risk Factors Associated with Herpes Simplex Virus-2 Infection in a Contemporary Cohort of HIV-Infected Persons in the United States. Sexually Transmitted Diseases, 39, 154-160.
https://doi.org/10.1097/OLQ.0b013e318239d7fd
[34]  Bauer, G.R., Khobzi, N. and Coleman, T.A. (2010) Herpes Simplex Virus Type 2 Seropositivity and Relationship Status among U.S. Adults Age 20 to 49: A Population-Based Analysis. BMC Infectious Diseases, 10, 359.
https://doi.org/10.1186/1471-2334-10-359
[35]  Tideman, R., Taylor, J., Marks, C., Seifert, C., Berry, G., Trudinger, B., et al. (2001) Sexual and Demographic Risk Factors for Herpes Simplex Type 1 and 2 in Women Attending an Antenatal Clinic. Sexually Transmitted Infections, 77, 413-415.
https://doi.org/10.1136/sti.77.6.413

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133